Research progress on fecal microbiota transplantation in tumor prevention and treatment

The application of fecal microbiota transplantation (FMT) as a therapeutic strategy to directly modify the makeup of the gut microbiota has made significant progress in the last few decades. The gut microbiota, a sizable microbial community present in the human gut, is essential for digestion, immun...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu Yijia, Chen Xi, Wu Qingming, Wang Qiang
Format: Article
Language:English
Published: De Gruyter 2025-04-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850265974158131200
author Wu Yijia
Chen Xi
Wu Qingming
Wang Qiang
author_facet Wu Yijia
Chen Xi
Wu Qingming
Wang Qiang
author_sort Wu Yijia
collection DOAJ
description The application of fecal microbiota transplantation (FMT) as a therapeutic strategy to directly modify the makeup of the gut microbiota has made significant progress in the last few decades. The gut microbiota, a sizable microbial community present in the human gut, is essential for digestion, immunomodulation, and nutrition absorption. Alternatively, a growing body of research indicates that gut microbiota is a key contributor to cancer, and intratumoral bacteria are considered to be crucial “accomplices” in the development and metastasis of malignancies. The exceptional clinical effectiveness of FMT in treating melanoma patients has been adequately established in earlier research, which has created new avenues for the diagnosis and treatment of cancer and sparked an increasing interest in the treatment and prevention of other cancers. However, further research on the function and mechanisms of the gut microbiota is required to properly comprehend the impact and role of these organisms in tumor regulation. In this article, we present a detailed account of the influence of FMT on the entire course of cancer patients’ illness and treatment, from tumor development, metastasis, and invasion, to the impact and application of treatment and prognosis, as well as address the associated mechanisms.
format Article
id doaj-art-e269e64191694c5daab68033b6ab6906
institution OA Journals
issn 2391-5412
language English
publishDate 2025-04-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj-art-e269e64191694c5daab68033b6ab69062025-08-20T01:54:16ZengDe GruyterOpen Life Sciences2391-54122025-04-0120130546310.1515/biol-2022-0954Research progress on fecal microbiota transplantation in tumor prevention and treatmentWu Yijia0Chen Xi1Wu Qingming2Wang Qiang3Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, ChinaWuchang Hospital Affiliated to Wuhan University of Science and Technology, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, ChinaWuchang Hospital Affiliated to Wuhan University of Science and Technology, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, ChinaWuchang Hospital Affiliated to Wuhan University of Science and Technology, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, ChinaThe application of fecal microbiota transplantation (FMT) as a therapeutic strategy to directly modify the makeup of the gut microbiota has made significant progress in the last few decades. The gut microbiota, a sizable microbial community present in the human gut, is essential for digestion, immunomodulation, and nutrition absorption. Alternatively, a growing body of research indicates that gut microbiota is a key contributor to cancer, and intratumoral bacteria are considered to be crucial “accomplices” in the development and metastasis of malignancies. The exceptional clinical effectiveness of FMT in treating melanoma patients has been adequately established in earlier research, which has created new avenues for the diagnosis and treatment of cancer and sparked an increasing interest in the treatment and prevention of other cancers. However, further research on the function and mechanisms of the gut microbiota is required to properly comprehend the impact and role of these organisms in tumor regulation. In this article, we present a detailed account of the influence of FMT on the entire course of cancer patients’ illness and treatment, from tumor development, metastasis, and invasion, to the impact and application of treatment and prognosis, as well as address the associated mechanisms.https://doi.org/10.1515/biol-2022-0954gut microbiotadysbiosiscancerfecal microbiota transplantationtherapy
spellingShingle Wu Yijia
Chen Xi
Wu Qingming
Wang Qiang
Research progress on fecal microbiota transplantation in tumor prevention and treatment
Open Life Sciences
gut microbiota
dysbiosis
cancer
fecal microbiota transplantation
therapy
title Research progress on fecal microbiota transplantation in tumor prevention and treatment
title_full Research progress on fecal microbiota transplantation in tumor prevention and treatment
title_fullStr Research progress on fecal microbiota transplantation in tumor prevention and treatment
title_full_unstemmed Research progress on fecal microbiota transplantation in tumor prevention and treatment
title_short Research progress on fecal microbiota transplantation in tumor prevention and treatment
title_sort research progress on fecal microbiota transplantation in tumor prevention and treatment
topic gut microbiota
dysbiosis
cancer
fecal microbiota transplantation
therapy
url https://doi.org/10.1515/biol-2022-0954
work_keys_str_mv AT wuyijia researchprogressonfecalmicrobiotatransplantationintumorpreventionandtreatment
AT chenxi researchprogressonfecalmicrobiotatransplantationintumorpreventionandtreatment
AT wuqingming researchprogressonfecalmicrobiotatransplantationintumorpreventionandtreatment
AT wangqiang researchprogressonfecalmicrobiotatransplantationintumorpreventionandtreatment